Emerging research indicates drugs like Ozempic, Wegovy, Mounjaro and Zepbound could be useful in treating a variety of health conditions ranging from Parkinson’s and addiction to anxiety and fatty liver disease.| Forbes
Drugs solely approved to treat obesity have minimal to no coverage on most ACA Marketplace plans. Wegovy, a semaglutide approved for weight loss, is included in just 1% of Marketplace plans, while Ozempic, which has the same active ingredient but is approved for diabetes treatment and sometimes used off-label for weight loss, is included in 82% of Marketplace plan formularies. Among ACA Marketplace plans with these drugs on formulary, prior authorization is required by most plans. All plans ...| Peterson-KFF Health System Tracker
The Investor Relations website contains information about Eli Lilly and Company's business for stockholders, potential investors, and financial analysts.| Eli Lilly and Company
Sleep apnea is a common condition that occurs when your breathing stops and restarts many times while you sleep. Learn about the causes, symptoms, and treatments of sleep apnea.| NHLBI, NIH
